| Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer CE Barbieri, SC Baca, MS Lawrence, F Demichelis, M Blattner, ... Nature genetics 44 (6), 685-689, 2012 | 1606 | 2012 |
| Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry C Giesen, HAO Wang, D Schapiro, N Zivanovic, A Jacobs, B Hattendorf, ... Nature methods 11 (4), 417-422, 2014 | 1313 | 2014 |
| WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer C Wissmann, PJ Wild, S Kaiser, S Roepcke, R Stoehr, M Woenckhaus, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003 | 425 | 2003 |
| Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation E Holler, G Rogler, H Herfarth, J Brenmoehl, PJ Wild, J Hahn, G Eissner, ... Blood 104 (3), 889-894, 2004 | 322 | 2004 |
| Automated Gleason grading of prostate cancer tissue microarrays via deep learning E Arvaniti, KS Fricker, M Moret, N Rupp, T Hermanns, C Fankhauser, ... Scientific reports 8 (1), 12054, 2018 | 305 | 2018 |
| Exploring the 3D molecular architecture of Escherichia coli type 1 pili E Hahn, P Wild, U Hermanns, P Sebbel, R Glockshuber, M Häner, ... Journal of molecular biology 323 (5), 845-857, 2002 | 279 | 2002 |
| Reliable detection of subclonal single-nucleotide variants in tumour cell populations M Gerstung, C Beisel, M Rechsteiner, P Wild, P Schraml, H Moch, ... Nature communications 3 (1), 811, 2012 | 269 | 2012 |
| Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer DN Church, E Stelloo, RA Nout, N Valtcheva, J Depreeuw, N Ter Haar, ... Journal of the National Cancer Institute 107 (1), dju402, 2015 | 267 | 2015 |
| Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis A Hamm, J Veeck, N Bektas, PJ Wild, A Hartmann, U Heindrichs, ... BMC cancer 8 (1), 1-15, 2008 | 249 | 2008 |
| Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma R Massoumi, S Kuphal, C Hellerbrand, B Haas, P Wild, T Spruss, A Pfeifer, ... Journal of Experimental Medicine 206 (1), 221-232, 2009 | 241 | 2009 |
| Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4 X Dai, W Gan, X Li, S Wang, W Zhang, L Huang, S Liu, Q Zhong, J Guo, ... Nature medicine 23 (9), 1063-1071, 2017 | 229 | 2017 |
| TRIM24 is an oncogenic transcriptional activator in prostate cancer AC Groner, L Cato, J de Tribolet-Hardy, T Bernasocchi, H Janouskova, ... Cancer cell 29 (6), 846-858, 2016 | 229 | 2016 |
| Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas MO Riener, F Stenner, H Liewen, C Soll, S Breitenstein, BC Pestalozzi, ... Hepatology 49 (5), 1602-1609, 2009 | 223 | 2009 |
| Serotonin promotes tumor growth in human hepatocellular cancer C Soll, JH Jang, MO Riener, W Moritz, PJ Wild, R Graf, PA Clavien Hepatology 51 (4), 1244-1254, 2010 | 215 | 2010 |
| Prediction of progression of non–muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study M Burger, MNM van der Aa, JMM van Oers, A Brinkmann, ... European urology 54 (4), 835-844, 2008 | 214 | 2008 |
| Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer JPP Theurillat, ND Udeshi, WJ Errington, T Svinkina, SC Baca, M Pop, ... Science 346 (6205), 85-89, 2014 | 208 | 2014 |
| Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer I Cima, R Schiess, P Wild, M Kaelin, P Schüffler, V Lange, P Picotti, ... Proceedings of the National Academy of Sciences 108 (8), 3342-3347, 2011 | 205 | 2011 |
| Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors E Klopocki, G Kristiansen, PJ Wild, I Klaman, E Castanos-Velez, G Singer, ... International journal of oncology 25 (3), 641-649, 2004 | 199 | 2004 |
| Bactericidal activities of lysozyme and aprotinin against Gram‐negative and Gram‐positive bacteria related to their basic character A Pellegrini, U Thomas, R Von Fellenberg, P Wild Journal of Applied Microbiology 72 (3), 180-187, 1992 | 198 | 1992 |
| Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases B Becker, G Multhoff, B Farkas, PJ Wild, M Landthaler, W Stolz, T Vogt Experimental dermatology 13 (1), 27-32, 2004 | 194 | 2004 |
Arndt HartmannProfessor für Pathologie, Universotät Erlangen-NürnbergVerified email at uk-erlangen.de
